Treffer: Development of a Machine Learning Model for Screening Sleep Apnea in Heart Failure Patients Using Sleep Sensor Data

Title:
Development of a Machine Learning Model for Screening Sleep Apnea in Heart Failure Patients Using Sleep Sensor Data
Source:
Gunasegarama, M, Dinesen, B, Müller Larsen, N, Ghamari Gilavai, G, Røge, K, Kirk Østergaard, M & Rovsing Jochumsen, M 2025, Development of a Machine Learning Model for Screening Sleep Apnea in Heart Failure Patients Using Sleep Sensor Data. in Good Evaluation - Better Digital Health. vol. 332, IOS Press, Studies in Health Technology and Informatics, vol. 332, pp. 62-66, EFMI Special Topic Conference 2025, Osnabrück, Germany, 20/10/2025. https://doi.org/10.3233/SHTI251496
Publisher Information:
IOS Press
Publication Year:
2025
Collection:
Aalborg University (AAU): Publications / Aalborg Universitet: Publikationer
Document Type:
Buch book part
File Description:
application/pdf
Language:
English
Relation:
info:eu-repo/semantics/altIdentifier/pmid/41041747; info:eu-repo/semantics/altIdentifier/isbn/978-1-64368-629-5
DOI:
10.3233/SHTI251496
Rights:
info:eu-repo/semantics/openAccess ; http://creativecommons.org/licenses/by-nc/4.0/
Accession Number:
edsbas.A4BD9EAC
Database:
BASE

Weitere Informationen

Sleep apnea (SA) is a prevalent disorder among individuals with heart failure (HF), often leading to complications. Early identification is essential for timely interventions and better outcomes. This study explores the feasibility of developing a screening tool for SA in patients with HF using data from the Future Patient Telerehabilitation program. A random forest classifier was used to develop a predictive model, achieving a promising receiver operating characteristic area under the curve (ROC-AUC) of 0.85, suggesting that the random forest classifier has the potential as a SA screening tool for HF patients. However, the study lacked key variables, such as oxygen saturation, that are strong predictors for SA assessment according to current literature; this limits the model's generalizability. Despite this, the findings indicate that the ML model shows promise for screening SA in HF patients, highlighting the need for high-quality, standardized data from future clinical trials to enhance its accuracy and clinical utility.